[Results of treatment of cyanotic heart defects in children]

Insights

Cyanotic heart disease treatment in children showed improved survival with advanced surgeries. However, surgical outcomes in Yugoslavia were worse than global standards, with a trend toward better results.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Defects
  • Cardiac Surgery

Context:

  • Cyanotic heart diseases are rare, severe congenital conditions requiring complex surgical interventions.
  • Advanced surgical procedures and improved perioperative care have enhanced survival and quality of life for affected children.

Purpose:

  • To analyze the outcomes of surgical treatment for cyanotic heart disease in children in Yugoslavia between 2000 and 2004.
  • To evaluate mortality rates and surgical results in comparison to international standards.

Summary:

  • A study of 308 children with cyanotic heart disease treated in Yugoslavia revealed varying mortality rates (11.8% for palliative, 12.5% for complete correction).
  • Open heart surgery was performed in 75.3% of cases, with outcomes generally worse than those reported by leading international centers.
  • Despite challenges, there was a discernible trend towards adopting new surgical techniques, reducing patient age at operation, and lowering mortality.

Impact:

  • Highlights disparities in pediatric cardiac surgery outcomes between a specific region and global benchmarks.
  • Underscores the importance of advanced surgical techniques and perioperative care in managing complex congenital heart diseases.
  • Suggests a need for continued advancement and adherence to international standards in pediatric cardiac surgery within the studied region.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...